BACKGROUND AND OBJECTIVES Hypoglycemia occurs in 5% to 15% of neonates in the
first few days. A significant proportion requires admission for intravenous fluids. Dextrose gel …

Aim The aim of this study was to evaluate dextrose gel in the management of neonatal
hypoglycaemia in the postnatal wards at an Australian tertiary level perinatal centre …

Background: Newborn infants with risk factors may require intravenous (IV) dextrose for
asymptomatic hypoglycemia. Administration of IV dextrose and transfer to the neonatal …

Objective Evaluate the impact of a neonatal hypoglycemia (NH) clinical pathway
implementing buccal dextrose gel in late preterm and term infants. Study design Quality …

Objective The use of oral dextrose gel (DG) reduces IV dextrose use. Prior studies used
weight-based dosing (WD), though barriers exist, and are mitigated using standard dosing …

Aims To determine the use of oral dextrose gel to treat neonatal hypoglycaemia in New
Zealand (NZ), to identify barriers and enablers to the implementation of the guideline and to …

Objective To evaluate whether glucose gel as a supplement to feedings in infants admitted
to the newborn nursery at risk for neonatal hypoglycemia (NH) reduces the frequency of …

Objectives To determine the impact of incorporating dextrose gel in the treatment of neonatal
hypoglycaemia (NH) and the role of feeding type in NH outcomes. Study design We …

Objective To test the hypothesis that prophylactic dextrose gel administered to newborn
infants at risk for hypoglycemia will increase the initial blood glucose concentration after the …

Background Neonatal hypoglycemia is common and can cause brain injury. Buccal dextrose
gel is effective for treatment of neonatal hypoglycemia, and when used for prevention may …